Postpartum pElvic Assisted Recovery With Leva
- Conditions
- Postpartum Pelvic Floor Function and Symptoms
- Interventions
- Device: Digital therapeutic motion-based device
- Registration Number
- NCT06609317
- Lead Sponsor
- University of South Florida
- Brief Summary
The goal of this prospective cohort study is to evaluate the feasibility of postpartum pelvic floor muscle training using an FDA-cleared digital therapeutic motion-based device.
In addition to assessing feasibility, investigators also will evaluate bladder and bowel function, pelvic organ prolapse symptoms, and vaginal and perineal pain in the immediate postpartum period and at 3 and 6 months postpartum. Investigators also will assess sexual function at 3 and 6 months postpartum.
Participants will use the motion-based device for postpartum pelvic floor muscle training and will complete electronically administered surveys at 3 and 6 months postpartum.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- Female
- Target Recruitment
- 25
- Spontaneous vaginal delivery within the last 4-8 weeks
- Age ≥ 18 years
- Ambulatory
- Willing and able to consent to participate.
- English speaking
- Owns a smartphone
- Operative or cesarean delivery
- Obstetric delivery at less than 20 weeks gestation
- Third- or fourth-degree perineal laceration
- Episiotomy
- Multiples
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Device Arm Digital therapeutic motion-based device Participants in this arm will use a digital therapeutic motion-based device for postpartum pelvic floor muscle training
- Primary Outcome Measures
Name Time Method Feasibility From enrollment to 6 months postpartum Feasibility will be assessed using participant reported discomfort with device use, ease of device use, net promotor score, patient satisfaction, and free text feedback on the device.
Perineal Pain From enrollment to 6 months postpartum Participants will complete validated surveys assessing perineal pain at baseline, 3 months postpartum, and 6 months postpartum.
- Secondary Outcome Measures
Name Time Method Bladder function From enrollment to 6 months postpartum Participants will complete validated surveys assessing bladder function at baseline, 3 months postpartum, and 6 months postpartum.
Bowel Function From enrollment to 6 months postpartum Participants will complete validated surveys assessing bowel function at baseline, 3 months postpartum, and 6 months postpartum.
Pelvic Organ Prolapse From enrollment to 6 months postpartum Participants will complete validated surveys assessing pelvic organ prolapse symptoms at baseline, 3 months postpartum, and 6 months postpartum.
Vaginal pain From enrollment to 6 months postpartum Participants will complete validated surveys assessing vaginal pain at baseline, 3 months postpartum, and 6 months postpartum.
Sexual function From enrollment to 6 months postpartum Participants will complete validated surveys assessing sexual function at 3 months postpartum and 6 months postpartum.